Fermion Oy Fermion Oy

X

Find the latest Drugs in Development and Pipeline Prospector News of Actylis.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Actylis
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
4 Tri Harbor Court Port Washington, NY 11050
Telephone
Telephone
+1 5166276000

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

left grey arrow
right gray arrow

Details:

Cascade Chemistry has been selected by Renibus Therapeutics, to produce the API for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for the treatment of high risk COVID-19 patients.


Lead Product(s): Stannus Protoporphyrin

Therapeutic Area: Infections and Infectious Diseases Product Name: RBT-9

Highest Development Status: Phase IIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Renibus Therapeutics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration June 16, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Algernon has made the decision to scale-up cGMP manufacturing of Ifenprodil to support its quickly evolving clinical program for acute lung injury in COVID-19 patients.


Lead Product(s): Ifenprodil Tartrate

Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

Highest Development Status: UndisclosedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Algernon Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration March 23, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY